Pawel Marcin Wisniewski

Director/Board Member at PURE BIOLOGICS S.A.

44 year

Health Technology

Profile

Pawel Marcin Wisniewski is currently serving as the Vice Chairman-Management Board at Helix Immuno-Oncology SA. He is also the Deputy Chairman-Supervisory Board at Pure Biologics SA and the Vice President-Management Board at 4cell Therapies SA. Previously, he held the position of Chief Executive Officer at Helix Polska Sp zoo and worked as a Project Manager at Adiuvo Investments SA from 2012 to 2016.

Pawel Marcin Wisniewski active positions

Companies	Position	Start
PURE BIOLOGICS S.A.	Director/Board Member	2023-05-25
Helix Immuno-Oncology SA Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland.	Corporate Officer/Principal	-

All active positions of Pawel Marcin Wisniewski

Former positions of Pawel Marcin Wisniewski

Companies	Position	End
Helix Polska Sp zoo Helix Polska Sp zoo Pharmaceuticals: MajorHealth Technology Helix Polska Sp zoo develops therapeutic products. The company is based in Warsaw, Poland.	Chief Executive Officer	-

See the detail of Pawel Marcin Wisniewski's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Pawel Marcin Wisniewski's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
PURE BIOLOGICS S.A.	Health Technology

Private companies	2
Helix Polska Sp zoo Helix Polska Sp zoo Pharmaceuticals: MajorHealth Technology Helix Polska Sp zoo develops therapeutic products. The company is based in Warsaw, Poland.	Health Technology
Helix Immuno-Oncology SA Helix Immuno-Oncology SA Pharmaceuticals: MajorHealth Technology Helix Immuno-Oncology SA engages in the research and development in the area of biotechnology. It develops technology and products with applications in cancer immunotherapy. The company was founded in 2013 and is headquartered in Gliwice, Poland.	Health Technology

See company connections